Branded GLP-1s (Wegovy, Mounjaro) are FDA-approved, mass-manufactured drugs with extensive clinical trial data
Published scientific literature has discussed these peptides in laboratory studies involving peptide biology, molecular signaling, receptor biology, protein interactions, extracellular matrix research, analytical chemistry, and experimental peptide models
Notification Number of NOM (National Organization for Medicines): 25080/15-03-2023 The product is not subject to licensing procedure
Novo Nordisk leaders changed their tune after the deal with Hims & Hers was finalized
As part of the deal, Caremark agreed to remove Zepbound from its commercial formulary
Initially developed for managing type 2 diabetes, tirzepatide has been shown to significantly aid in weight loss by reducing appetite, increasing satiety, and improving glucose control